logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (ii) New outpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates11.328.046.149.646.846.945.238.4387385918
Cocaine10.025.835.836.739.237.737.323.2324153852
Stimulants3.65.23.73.13.32.92.92.54940921
Hypnotics and sedatives1.31.01.42.74.16.19.721.32295502
Hallucinogens0.20.40.40.30.20.20.20.1387109
Volatile substances0.61.00.00.10.00.10.20.1640187
Cannabis 71.537.411.66.85.14.12.96.23567210682
Other substances 1.51.21.00.81.31.91.68.31484349
Total16619527932365911035619532651707129811657122520

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR 

 Last data available from Spain and Poland refer to 2008. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011